Eton Pharmaceutical ETON
Ownership & positioning
Who holds it, who is betting against it, and where the big money is moving
Short-sale volume as % of daily volume
Large-order net flow, last 20 sessions
Net of large-order buying minus selling, in USD. Over this window: +$4.58M (13 inflow days, 7 outflow days).
Net flow by order size, last 20 sessions
Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.
The five largest holders on file together own 31.5% of shares outstanding.
Largest holders
By investor type
Reported short interest has risen from 5.00% to 6.95% of float over the last 6 biweekly reports (14 Aug 2026 to 30 Oct 2026).
Recent institutional activity
| Holder | Type | Period | Share change | New stake |
|---|---|---|---|---|
| FMR | Mutual Fund | 2026/Q3 | +821,438 | 2.9% |
| Vanguard Capital Management, LLC | Mutual Fund | 2026/Q3 | +226,772 | 4.2% |
| BlackRock | Mutual Fund | 2026/Q3 | +200,081 | 7.3% |
| Dimensional Fund Advisors | Mutual Fund | 2026/Q3 | +170,405 | 0.7% |
| Geode Capital Management, LLC | Mutual Fund | 2026/Q3 | +112,095 | 2.7% |
| Invesco Capital Management LLC | Mutual Fund | 2026/Q3 | +90,086 | 0.4% |
| RPg Family Wealth Advisory, LLC | Mutual Fund | 2026/Q3 | +85,274 | 0.3% |
| Vanguard Portfolio Management, LLC | Mutual Fund | 2026/Q3 | +75,421 | 0.9% |
| State Street Global Advisors | Mutual Fund | 2026/Q3 | +73,757 | 2.7% |
| Raymond James Financial, Inc. | Public Company | 2026/Q3 | +71,970 | 0.3% |
| Squarepoint OPS LLC | Hedge Fund | 2026/Q3 | +70,243 | 0.5% |
| Wasatch Advisors LP | Mutual Fund | 2026/Q3 | +65,060 | 0.5% |
| Principal Global Investors, LLC | Mutual Fund | 2026/Q3 | +61,257 | 0.2% |
| Principal Global Investors, LLC | Mutual Fund | 2026/Q3 | +60,147 | 0.2% |
| Sean Brynjelsen | Individual/Insider | 2026/Q3 | +127,500 | 3.3% |
Institutional buy/sell activity by reporting period, largest moves first.
Insider transactions
| Date | Insider | Title | Transaction | Shares | Price | Held after |
|---|---|---|---|---|---|---|
| 9 Nov 2026 | Charles Casamento | Independent Director | Derivative Exercise and Sale | -80,555 | $67.87 | 68,420 |
| 9 Nov 2026 | Ipek Erdogan-Trinkaus | Chief Commercial Officer | Derivative Exercise and Sale | -3,500 | $67.88 | 4,081 |
| 5 Oct 2026 | David Krempa | Chief Business Officer | Intent to Sell (Form 144) | -4,166 | $55.07 | – |
| 5 Oct 2026 | David Krempa | Chief Business Officer | Derivative Exercise and Sale | -4,166 | $55.07 | 43,381 |
| 1 Oct 2026 | David Krempa | Chief Business Officer | Derivative Exercise and Retained | +6,356 | – | 43,381 |
| 27 Aug 2026 | Paul Maier | Independent Director | Derivative Exercise and Sale | -50,000 | $61.77 | 72,245 |
| 27 Aug 2026 | Paul Maier | Independent Director | Other Derivative Acquisition | +12,500 | $7.31 | – |
| 27 Aug 2026 | Paul Maier | Independent Director | Derivative Exercise and Retained | +12,500 | $7.31 | 72,245 |
| 23 Aug 2026 | David Krempa | Chief Business Officer | Derivative Exercise and Sale | -25,000 | $65.07 | 37,025 |
| 19 Aug 2026 | Sean Brynjelsen | Chief Executive Officer | Open Market Disposition | -100,000 | $62.65 | 961,194 |
| 18 Aug 2026 | Sean Brynjelsen | Chief Executive Officer | Intent to Sell (Form 144) | -100,000 | $63.43 | – |
| 30 Jul 2026 | Paul Maier | Independent Director | Other Derivative Acquisition | +10,000 | – | 10,000 |
| 30 Jul 2026 | Charles Casamento | Independent Director | Other Derivative Acquisition | +10,000 | – | 10,000 |
| 30 Jul 2026 | Norbert Riedel | Independent Chairperson | Other Derivative Acquisition | +10,000 | – | 10,000 |
| 30 Jul 2026 | David Krempa | Chief Business Officer | Other Derivative Acquisition | +128,985 | – | 128,985 |
| 30 Jul 2026 | Jennifer Adams | Independent Director | Other Derivative Acquisition | +10,000 | – | 10,000 |
| 30 Jul 2026 | Judith Matthews | Chief Financial Officer & Secretary | Other Derivative Acquisition | +32,246 | – | 32,246 |
| 30 Jul 2026 | Danka Radosavljevic | Chief Operating Officer | Initial Statement of Beneficial | +0 | – | 27,233 |
| 30 Jul 2026 | Ipek Erdogan-Trinkaus | Chief Commercial Officer | Other Derivative Acquisition | +80,000 | – | 80,000 |
| 13 Jul 2026 | Opaleye Management Inc. | Open Market Disposition | -28,315 | $37.54 | 2,705,000 |
From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.
Short interest, by report
| Report date | Shares short | % of float | Days to cover |
|---|---|---|---|
| 30 Oct 2026 | 1,986,167 | 6.9% | 5.4 |
| 15 Oct 2026 | 1,943,339 | 6.8% | 3.3 |
| 30 Sep 2026 | 1,834,090 | 6.4% | 2.9 |
| 15 Sep 2026 | 1,542,982 | 5.4% | 3.5 |
| 31 Aug 2026 | 1,347,971 | 4.7% | 2.0 |
| 14 Aug 2026 | 1,427,797 | 5.0% | 2.2 |
No comments yet — be the first to weigh in on ETON.
Sign in to join the discussion.